---
category: news
title: "Pharma firm makes RSV vaccine candidate breakthrough with artificial intelligence"
excerpt: "Biopharmaceutical firm Poolbeg Pharma has found a number of RSV vaccine candidates via artificial intelligence (AI), in a landmark move in finding a"
publishedDateTime: 2022-12-21T09:21:00Z
originalUrl: "https://www.cityam.com/pharma-firm-makes-rsv-vaccine-candidate-breakthrough-with-artificial-intelligence/"
webUrl: "https://www.cityam.com/pharma-firm-makes-rsv-vaccine-candidate-breakthrough-with-artificial-intelligence/"
ampWebUrl: "https://www.cityam.com/pharma-firm-makes-rsv-vaccine-candidate-breakthrough-with-artificial-intelligence/?amp=1"
cdnAmpWebUrl: "https://www-cityam-com.cdn.ampproject.org/c/s/www.cityam.com/pharma-firm-makes-rsv-vaccine-candidate-breakthrough-with-artificial-intelligence/?amp=1"
type: article
quality: 54
heat: 64
published: false

provider:
  name: City A.M.
  domain: cityam.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://www.cityam.com/wp-content/uploads/2021/10/1219071027.jpg"
    width: 1024
    height: 683
    isCached: true

related:
  - title: "Lantern Pharma’s New Drug Candidate for Mantle Cell Lymphoma Shows Promise"
    excerpt: "The Dallas-based biopharmaceutical company expects to begin testing the drug candidate in a “first in human” trial in mid-2023. The drug was developed using the publicly traded company’s AI/ML drug development platform."
    publishedDateTime: 2022-12-23T00:08:00Z
    webUrl: "https://dallasinnovates.com/lantern-pharmas-new-drug-candidate-for-mantle-cell-lymphoma-shows-promise/"
    type: article
    provider:
      name: Dallas Innovates
      domain: dallasinnovates.com
    quality: 22
    images:
      - url: "https://s24806.pcdn.co/wp-content/uploads/2022/12/Panna-Sharma_Lantern-Pharma.jpg"
        width: 970
        height: 465
        isCached: true

secured: "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;Y2RCX63SdbQVnGiLhncKeQ=="
---

